| Ms Erys Katherine Tea, LCSW | |
|
215 Fidalgo Avenue, Suite 204 C, Kenai, AK 99611 | |
| (907) 283-6551 | |
| (907) 283-6553 |
| Full Name | Ms Erys Katherine Tea |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 215 Fidalgo Avenue, Kenai, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518005172 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 196 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Erys Katherine Tea, LCSW P.o. Box 288, Kenai, AK 99611 Ph: (907) 283-6551 | Ms Erys Katherine Tea, LCSW 215 Fidalgo Avenue, Suite 204 C, Kenai, AK 99611 Ph: (907) 283-6551 |
News Archive
"China could be considering relaxing its ... one-child policy," which "is increasingly being seen as an impediment to growth and the harbinger of social problems," such as a declining workforce, Reuters reports.
Early menopause increases the risk of bladder cancer for smokers - this was the finding of an interdisciplinary research group, led by urologist Mohammad Abufaraj from MedUni Vienna's Department of Urology and Division of Epidemiology and other international university hospitals, using data from 230,000 participants in the longitudinal Nurses' Health Studies I and II.
An 84-year-old Texas man recently became the oldest living kidney donor in the country after donating one of his kidneys to his 72-year old neighbor at Houston Methodist Hospital.
Catalyst Pharmaceutical Partners, Inc. announced today that it has signed a definitive Clinical Trial Agreement (CTA) with the National Institute on Drug Abuse (NIDA) to jointly conduct a U.S. Phase II(b) clinical trial evaluating CPP-109, Catalyst's formulation of vigabatrin, for the treatment of cocaine addiction. As part of the CTA, NIDA, under their agreement with Veteran's Administration Cooperative Studies Program, will provide substantial resources for the estimated $10 million trial cost.
An investigational drug called regorafenib slowed the progression of tumors and lengthened the lives of patients with metastatic colorectal cancer, an international phase III clinical trial found. The findings were presented today at the Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology in San Francisco by Mayo Clinic oncologist Axel Grothey, M.D., principal investigator of the trial in the United States.
› Verified 4 days ago
Michael J Wolfe, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 110 N Willow St, Kenai, AK 99611 Phone: 907-283-6693 Fax: 907-283-7088 | |
Leah Williamson, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 609 Marine Ave, Kenai, AK 99611 Phone: 076-001-6849 Fax: 907-308-5882 | |
Fridrik Rafn Gudmundsson, L.C.S.W. Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 510 Upland St, Kenai, AK 99611 Phone: 907-335-7315 Fax: 888-491-3243 | |
Kimberly Ann Haviland, LCSW, CDCI, ADMIN. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 11312 Kenai Spur Hwy, Suite 39, Kenai, AK 99611 Phone: 907-395-4106 Fax: 907-283-4236 | |
Mrs. Terrya Elder, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 320 S Spruce St, Kenai, AK 99611 Phone: 907-283-7635 Fax: 907-283-9575 |